A Curated Platform of Equity & Options Market Intelligence
Select Page

CUE

Search by
TICKER SYMBOL

Cue Biopharma Inc

Sector: Professional, Scientific, and Technical Services
Industry: Research and Development in Biotechnology

3.09

0.05

(1.645%)

Volume:

167,103

52 week range:

2.18 - 6.29

Market Cap:

133.001M

Company Description:

Cue Biopharma, a clinical-stage biopharmaceutical company, is engineering a novel class of injectable biologics to selectively engage and modulate targeted T cells directly within the patient's body to transform the treatment of cancer, infectious diseases and autoimmune diseases. The company's proprietary platform, Immuno-STAT ™(Selective Targeting and Alteration of T cells) is designed to harness the body's intrinsic immune system without the need for ex vivo manipulation.